Gene selective mRNA cleavage inhibits the development of Plasmodium falciparum

Yoann Augagneur, Donna Wesolowski, Hyun Seop Tae, Sidney Altman, Choukri Ben Mamoun

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Unique peptide-morpholino oligomer (PMO) conjugates have been designed to bind and promote the cleavage of specific mRNA as a tool to inhibit gene function and parasite growth. The new conjugates were validated using the P. falciparum gyrase mRNA as a target (PfGyrA). Assays in vitro demonstrated a selective degradation of the PfGyrA mRNA directed by the external guide sequences, which are morpholino oligomers in the conjugates. Fluorescence microscopy revealed that labeled conjugates are delivered into Plasmodium-infected erythrocytes during all intraerythrocytic stages of parasite development. Consistent with the expression of PfGyrA in all stages of parasite development, proliferation assays showed that these conjugates have potent antimalarial activity, blocking early development, maturation, and replication of the parasite. The conjugates were equally effective against drug sensitive and resistant P. falciparum strains. The potency, selectivity, and predicted safety of PMO conjugates make this approach attractive for the development of a unique class of target-specific antimalarials and for largescale functional analysis of the malarial genome.

Original languageEnglish (US)
Pages (from-to)6235-6240
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume109
Issue number16
DOIs
StatePublished - Apr 17 2012
Externally publishedYes

Fingerprint

Plasmodium falciparum
Morpholinos
Parasites
Messenger RNA
Antimalarials
Genes
Peptides
Plasmodium
RNA Stability
Fluorescence Microscopy
Erythrocytes
Genome
Safety
Growth
Pharmaceutical Preparations

Keywords

  • Nuclease resistance
  • RNase P

ASJC Scopus subject areas

  • General

Cite this

Gene selective mRNA cleavage inhibits the development of Plasmodium falciparum. / Augagneur, Yoann; Wesolowski, Donna; Tae, Hyun Seop; Altman, Sidney; Mamoun, Choukri Ben.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 109, No. 16, 17.04.2012, p. 6235-6240.

Research output: Contribution to journalArticle

Augagneur, Yoann ; Wesolowski, Donna ; Tae, Hyun Seop ; Altman, Sidney ; Mamoun, Choukri Ben. / Gene selective mRNA cleavage inhibits the development of Plasmodium falciparum. In: Proceedings of the National Academy of Sciences of the United States of America. 2012 ; Vol. 109, No. 16. pp. 6235-6240.
@article{3f401428904f4acdae98f15614aea4d3,
title = "Gene selective mRNA cleavage inhibits the development of Plasmodium falciparum",
abstract = "Unique peptide-morpholino oligomer (PMO) conjugates have been designed to bind and promote the cleavage of specific mRNA as a tool to inhibit gene function and parasite growth. The new conjugates were validated using the P. falciparum gyrase mRNA as a target (PfGyrA). Assays in vitro demonstrated a selective degradation of the PfGyrA mRNA directed by the external guide sequences, which are morpholino oligomers in the conjugates. Fluorescence microscopy revealed that labeled conjugates are delivered into Plasmodium-infected erythrocytes during all intraerythrocytic stages of parasite development. Consistent with the expression of PfGyrA in all stages of parasite development, proliferation assays showed that these conjugates have potent antimalarial activity, blocking early development, maturation, and replication of the parasite. The conjugates were equally effective against drug sensitive and resistant P. falciparum strains. The potency, selectivity, and predicted safety of PMO conjugates make this approach attractive for the development of a unique class of target-specific antimalarials and for largescale functional analysis of the malarial genome.",
keywords = "Nuclease resistance, RNase P",
author = "Yoann Augagneur and Donna Wesolowski and Tae, {Hyun Seop} and Sidney Altman and Mamoun, {Choukri Ben}",
year = "2012",
month = "4",
day = "17",
doi = "10.1073/pnas.1203516109",
language = "English (US)",
volume = "109",
pages = "6235--6240",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "16",

}

TY - JOUR

T1 - Gene selective mRNA cleavage inhibits the development of Plasmodium falciparum

AU - Augagneur, Yoann

AU - Wesolowski, Donna

AU - Tae, Hyun Seop

AU - Altman, Sidney

AU - Mamoun, Choukri Ben

PY - 2012/4/17

Y1 - 2012/4/17

N2 - Unique peptide-morpholino oligomer (PMO) conjugates have been designed to bind and promote the cleavage of specific mRNA as a tool to inhibit gene function and parasite growth. The new conjugates were validated using the P. falciparum gyrase mRNA as a target (PfGyrA). Assays in vitro demonstrated a selective degradation of the PfGyrA mRNA directed by the external guide sequences, which are morpholino oligomers in the conjugates. Fluorescence microscopy revealed that labeled conjugates are delivered into Plasmodium-infected erythrocytes during all intraerythrocytic stages of parasite development. Consistent with the expression of PfGyrA in all stages of parasite development, proliferation assays showed that these conjugates have potent antimalarial activity, blocking early development, maturation, and replication of the parasite. The conjugates were equally effective against drug sensitive and resistant P. falciparum strains. The potency, selectivity, and predicted safety of PMO conjugates make this approach attractive for the development of a unique class of target-specific antimalarials and for largescale functional analysis of the malarial genome.

AB - Unique peptide-morpholino oligomer (PMO) conjugates have been designed to bind and promote the cleavage of specific mRNA as a tool to inhibit gene function and parasite growth. The new conjugates were validated using the P. falciparum gyrase mRNA as a target (PfGyrA). Assays in vitro demonstrated a selective degradation of the PfGyrA mRNA directed by the external guide sequences, which are morpholino oligomers in the conjugates. Fluorescence microscopy revealed that labeled conjugates are delivered into Plasmodium-infected erythrocytes during all intraerythrocytic stages of parasite development. Consistent with the expression of PfGyrA in all stages of parasite development, proliferation assays showed that these conjugates have potent antimalarial activity, blocking early development, maturation, and replication of the parasite. The conjugates were equally effective against drug sensitive and resistant P. falciparum strains. The potency, selectivity, and predicted safety of PMO conjugates make this approach attractive for the development of a unique class of target-specific antimalarials and for largescale functional analysis of the malarial genome.

KW - Nuclease resistance

KW - RNase P

UR - http://www.scopus.com/inward/record.url?scp=84860004871&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84860004871&partnerID=8YFLogxK

U2 - 10.1073/pnas.1203516109

DO - 10.1073/pnas.1203516109

M3 - Article

VL - 109

SP - 6235

EP - 6240

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 16

ER -